Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia

Acta Psychiatrica Scandinavica

Volumn 114, Issue 1, 2006, Pages 40-48

  Wang, H L ^a   Wang, G H ^a   Li, Q Y ^a   Shu, C ^a   Jiang, M S ^b   Guo, Y ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Prevalence; Schizophrenia; Signs and symptoms; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SERODIAGNOSIS; SYMPTOM; TOXOPLASMOSIS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REFERENCE VALUES; RISK FACTORS; SCHIZOPHRENIA; STATISTICS; STATISTICS AS TOPIC; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CEREBRAL;

EID: 33745111015     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00780.x     Document Type: Article

References (40)

1. Berman KF Torrey EF Daniel DG Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992 49: 927 934.
2. Bhopale GM. Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 2003 26: 213 222.
3. Torrey EF. Are we overestimating the genetic contribution to schizophrenia Schizophr Bull 1992 18: 159 170.
4. Torrey EF Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cat Schizophr Bull 1995 21: 167 171.
5. Torrey EF Rawlings R Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res 2000 46: 17 23.
6. Torrey EF Yolken RH. Toxoplasma gondii and Schizophrenia. Emerg Infect Dis 2003 9: 1375 1380.
7. McGrath J. Universal interventions for the primary prevention of schizophrenia. Aust N Z J Psychiatry 2000 34 ( suppl. 58 64.
8. Ledgerwood LG Ewald PW Cochran GM. Genes, Germs, and schizophrenia: an evolutionary perspective. Perspec Biol Med 2003 46: 317 348.
9. Tochigi M Okazaki Y Kato N Sasaki T. What causes seasonality of birth in schizophrenia Neurosci Res 2004 48: 1 11.
10. Buentello E. Preliminary report on the relationship between toxoplasmosis, lysergic acid and schizophrenia. Gac Med Mex 1958 88: 693 708, 709 710.
11. Hay J Hutchison WM. Toxoplasma gondii- an environmental contaminant. Ecol Dis 1983 2: 33 43.
12. Gagne SS. Toxoplasmosis. Prim Care UpdateOb/Gyns 2001 8: 122 126.
13. Witting PA. Learning capacity and memory of normal and Toxoplasma-infected laboratory rats and mice. Z Parasitenkd 1979 61: 29 51.
14. Hay J Aitken PP Graham DI. Toxoplasma infection and response to novelty in mice. Z Parasitenkd 1984 70: 575 588.
15. Berdoy M Webster JP Macdonald DW. Parasite-altered behaviour: is the effect of Toxoplasma gondii on Rattus norvegicus specific Parasitology 1995 111: 403 409.
16. Berdoy M Webster JP Macdonald DW. Fatal attraction in rat infected with Toxoplasma gondii. Proc R Soc Lond B 2000 267: 1591 1594.
17. Webster JP Brunton CF Macdonald DW. Effects of Toxoplasma gondii upon neophobia behavior in wild brown rats Rattus norvegicus. Parasitology 1994 109: 37 43.
18. Flegr J Zitkova S Kodym P Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 1996 113: 49 54.
19. Flegr J Kodym P Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol 2000 53: 57 68.
20. Flegr J Preiss M Klose J Havlicek J Vitakova M Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis Biol Psychol 2003 63: 253 268.
21. Holliman RE. Toxoplasmosis, behavior, and personality. J Infect 1997 35: 105 110.
22. Havlicek J Gasova Z Smith AP Zvara K Flegr J. Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology 2001 122: 515 520.
23. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985 79: 153 157.
24. Brown AS Schaefer CA Quesenberry CP Liu L Babulas VP Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005 162: 767 773.
25. Delgado GG Garcia LJ. Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev Cubana Med Trop 1979 31: 225 231.
26. Li QY Luo XN Li L Tong F. Comparative study on Toxoplasma infection in patients with schizophrenia and affective disorder. Med J Wuhan Univ (Chinese) 1999 20: 222 223.
27. Gu H Yolken RH Phillips M et al. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia (abstract). Schizophr Res 2001 49: 53.
28. Yolken RH Bachmann S Rouslanova I et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infect Dis 2001 32: 842 844.
29. Leweke FM Gerth CW Koethe D et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004 254: 4 8.
30. Si TM Yang JZ Shu L et al. The reliability, validity of Positive and Negative Syndrome Scale (Chinese version) and its implication. Chinese J Ment Health 2004 18: 45 47.
31. Yang LD. The situation of research on toxoplasmosis in Hubei Province. In: Enshu Y. ed. Toxoplasmosis in China. Hongkong: Asia Medicine Publishing House, 2000: 258 263.
32. Rimon R Halonen P. Herpes simplex virus infection and depressive illness. Dis Nerv Syst 1969 30: 338 340.
33. Kar N Misra B. Toxoplasma seropositivity and depression: a case report. BMC Psychiatry 2004 4: 1
34. Fairweather WR. Comparing proportion exposed in case-control studies using several control groups. Am J Epidemiol 1987 126: 170 178.
35. Lindenmayer JP Grochowski S Hyman RB. Five-factor model of schizophrenia: replication across samples. Schizophr Res 1995 14: 229 234.
36. Lancon C Aghababian V Llorca PM Bernard D Auquier P. An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale. Can J Psychiatry 1999 44: 893 900.
37. Jones-Brando L Torrey EF Yolken RH. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003 62: 237 244.
38. Piekarski G. Behavioral alterations caused by parasitic infection in case of latent Toxoplasma infection. Zentralbl Bakteriol Mikrobiol Hyg 1981 250: 403 406.
39. Hill K Mann L Laws KR Stephenson CME Nimmo-Smith I McKenna PJ. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand 2004 110: 243 256.
40. Boks MPM Liddle PF Burgerhof JGM Knegtering R Van den Bosch R-J. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand 2004 110: 29 35.